ACROBIOSYSTEMS CO.,LTD. — Investor Relations & Filings
ACROBIOSYSTEMS CO.,LTD. is a global biotechnology company specializing in the development and manufacturing of high-quality recombinant proteins and critical reagents for the life sciences industry. The company provides a comprehensive portfolio of products designed to accelerate the development of target therapeutics, including antibodies, cell and gene therapies, and vaccines. Key offerings include a wide range of biotinylated proteins, enzymes, and assay kits characterized by high bioactivity and batch-to-batch consistency. ACROBIOSYSTEMS supports drug discovery and clinical development through specialized platforms for protein engineering and characterization. Its products serve a diverse client base of pharmaceutical companies, biotechnology firms, and academic research institutions worldwide, focusing on therapeutic areas such as oncology, immunology, and infectious diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公司、控股股东、实际控制人、发起人、主要股东、董监高及中介机构与投资者保护相关的承诺 | 2021-09-23 | Chinese | |
| 公司内部控制鉴证报告 | 2021-09-23 | Chinese | |
| 公司关于本次发行的董事会决议 | 2021-09-23 | Chinese | |
| 关于公司首次公开发行人民币普通股并在创业板上市之律师工作报告 | 2021-09-23 | Chinese | |
| 公司首次公开发行股票并在创业板上市之发行保荐工作报告 | 2021-09-23 | Chinese | |
| 公司最近三年财务会计报告、审计报告及最近一期审阅报告 | 2021-09-23 | Chinese |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2021
15 filings
| |||||
| 44572373 | 公司、控股股东、实际控制人、发起人、主要股东、董监高及中介机构与投资者保护相关的承诺 | 2021-09-23 | Chinese | ||
| 44570962 | 公司内部控制鉴证报告 | 2021-09-23 | Chinese | ||
| 44570681 | 公司关于本次发行的董事会决议 | 2021-09-23 | Chinese | ||
| 44570643 | 关于公司首次公开发行人民币普通股并在创业板上市之律师工作报告 | 2021-09-23 | Chinese | ||
| 44570617 | 公司首次公开发行股票并在创业板上市之发行保荐工作报告 | 2021-09-23 | Chinese | ||
| 44570569 | 公司最近三年财务会计报告、审计报告及最近一期审阅报告 | 2021-09-23 | Chinese | ||
| 44570198 | 公司关于设立以来股本演变情况的说明及其董事、监事、高级管理人员的确认意见 | 2021-09-23 | Chinese | ||
| 44570180 | 公司关于本次发行的股东大会决议 | 2021-09-23 | Chinese | ||
| 44570078 | 关于公司首次公开发行人民币普通股并在创业板上市之法律意见书 | 2021-09-23 | Chinese | ||
| 44570066 | 公司首次公开发行股票并在创业板上市之招股说明书 | 2021-09-23 | Chinese | ||
| 44570063 | 公司控股股东、实际控制人对招股说明书的确认意见 | 2021-09-23 | Chinese | ||
| 44570053 | 中国证监会关于同意公司首次公开发行股票注册的批复 | 2021-09-23 | Chinese | ||
| 44570045 | 公司首次公开发行股票并在创业板上市之发行保荐书 | 2021-09-23 | Chinese | ||
| 44570026 | 公司经注册会计师鉴证的非经常性损益明细表（三年及一期） | 2021-09-23 | Chinese | ||
| 44569572 | 公司章程（草案） | 2021-09-23 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ACROBIOSYSTEMS CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56034/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56034 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56034 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56034 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56034}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ACROBIOSYSTEMS CO.,LTD. (id: 56034)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.